** Shares of drugmaker ANI Pharmaceuticals ANIP.O rise 1.5% to $72.60
** Raises 2025 per-share profit forecast to between $6.27 and $6.62, compared with between $6.12 and $6.49 earlier
** Expects full-year revenue of $768 million-$793 million, compared with previously projected $756 million-$776 million
** Quarterly revenue jumped 43.4% to $197.1 million, above analysts' estimates of $180.68 million - data compiled by LSEG
** Including session's moves, stock up 33% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。